comprehensive -WSS

comprehensive

author：focus 2025-09-06 04:15:21 - browse：788

Cheryl Meier had watched clinical trial enrollment announcements for years — but always for her sons’ type 1 diabetes, never for herself. Her OB-GYN had put her on Effexor for her depression 20 years ago, and it worked well enough — she could sleep for the first time in her life, and she no longer cried at every little thing. But it never worked for her dark thoughts.

But then she retired, and then she had time, and then she saw an email — “I guess once your name gets on a list, it’s there,” she said — for an experimental depression drug called zuranolone.

Unlike today’s crowded market of SSRIs, prescribed once and taken for months, years, or even indefinitely, zuranolone, developed by Sage Therapeutics, promises something different.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： Neuroscience’s long legacy of racism

WSS

American woman, child freed after being kidnapped in Haiti last month

Friends ask where James Watson's attitudes about race came from

Nurses recount patients attacks

Asbestos, a deadly carcinogen, banned by EPA

Colonoscopy prep: Liquid

Physicians and social media: If you see something, say something?

focus

comprehensive

explore

In Memoriam: Notable people who died in 2023

Creating egg and sperm cells from stem cells raises ethical issues

DIEP, the 'gold standard' of breast reconstruction, is under threat

AstraZeneca to buy developer of next

How to save PrEP access — and even expand it

Maui's cultural, historic landmarks damaged in the devastating wildfires

How to save PrEP access — and even expand it

Friends ask where James Watson's attitudes about race came from

New air purifier tech could be key to improving indoor air quality

For Cytokinetics, FDA rejection of heart drug would help, not hinder

leisure time

Neuroscience’s long legacy of racism

Wayne Brady comes out as pansexual: 'Free to love whomever I want'

Anavex keeps shifting the goalposts in its clinical trials

In same hospitals, Black patients receive fewer opioids than white patients

Maui's cultural, historic landmarks damaged in the devastating wildfires

In same hospitals, Black patients receive fewer opioids than white patients

hotspot

leisure time

Wikipedia

leisure time